Insider · CIK 0001827590

Reilly Thomas Charles

Reports to the SEC for 2 companies · STAMFORD, CT

sec.gov

Transactions

Companies

Filings

CIK

0001827590

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-01	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+16.7K sh	—	—	102,514
2024-07-01	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−8,209 sh	$0.69	−$5,664.21	94,305
2024-07-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−16.7K sh	—	—	16,666
2024-06-20	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+33.3K sh	—	—	102,264
2024-06-20	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−16.4K sh	$0.73	−$12K	85,847
2024-06-20	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−33.3K sh	—	—	33,333
2024-02-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP and CFO	AAward	+116K sh	—	—	116,000
2024-02-01	AMRNAMARIN CORP PLC\UK · Stock Option (right to buy)A Award	EVP and CFO	AAward	+418K sh	—	—	418,000
2024-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+44.9K sh	—	—	93,483
2024-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−24.6K sh	$1.24	−$30.4K	68,931
2024-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−44.9K sh	—	—	89,867
2024-01-10	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+51.5K sh	—	—	76,875
2024-01-10	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−28.3K sh	$0.97	−$27.5K	48,550
2024-01-10	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP and CFO	AAward	+51.5K sh	—	—	0
2024-01-10	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−51.5K sh	—	—	0
2023-07-19	AMRNAMARIN CORP PLC\UK · Stock Option (right to buy)A Award	EVP and CFO	AAward	+404K sh	$1.08	+$437K	404,400
2023-07-01	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+16.7K sh	—	—	33,584
2023-07-01	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−8,209 sh	$1.19	−$9,768.71	25,375
2023-07-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−16.7K sh	—	—	33,333
2023-06-20	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+33.3K sh	—	—	33,334
2023-06-20	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP and CFO	FTax Payment	−16.4K sh	$1.19	−$19.5K	16,917
2023-06-20	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−33.3K sh	—	—	66,666
2023-02-21	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+270K sh	—	—	269,600
2023-02-21	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	EVP and CFO	AAward	+135K sh	—	—	134,800
2023-02-21	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	EVP and CFO	AAward	+50K sh	—	—	50,000
2022-07-01	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+100K sh	—	—	100,000
2022-07-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	EVP and CFO	AAward	+100K sh	—	—	100,000
2022-03-03	TVRDTvardi Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,044 sh	$11.38	−$23.3K	37,811
2022-02-28	TVRDTvardi Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+5,333 sh	$10.29	+$54.9K	39,855
2022-02-25	TVRDTvardi Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+20K sh	—	—	34,522
2022-02-25	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2021-12-17	TVRDTvardi Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+11.2K sh	—	—	14,522
2021-08-30	TVRDTvardi Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,982 sh	$14.20	−$28.1K	3,352
2021-08-24	TVRDTvardi Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+5,334 sh	—	—	5,334
2020-10-01	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
Jul 14
Reilly Thomas Charles0000950170-24-079717
SEC(opens sec.gov)
Jun 214
Reilly Thomas Charles0000950170-24-076300
SEC(opens sec.gov)
Feb 94
Reilly Thomas Charles0000950170-24-013289
SEC(opens sec.gov)
Feb 24
Reilly Thomas Charles0000950170-24-010534
SEC(opens sec.gov)
Jan 124
Reilly Thomas Charles0000950170-24-004305
SEC(opens sec.gov)
Jul 214
Reilly Thomas Charles0000950170-23-033855
SEC(opens sec.gov)
Jul 54
Reilly Thomas Charles0000899243-23-016904
SEC(opens sec.gov)
Jun 224
Reilly Thomas Charles0000899243-23-016257
SEC(opens sec.gov)

Companies

Address

C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET

STAMFORD, CT, 06902